Thiosulfate reduces calcium phosphate nephrolithiasis

Journal of the American Society of Nephrology

Volumn 20, Issue 6, 2009, Pages 1246-1253

  Asplin, John R ^a   Donahue, Susan E ^a   Lindeman, Christina ^a   Michalenka, Anne ^b   Strutz, Kelly Laplante ^b   Bushinsky, David A ^b  

^a LithoLink Corporation   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALCIUM PHOSPHATE; CITRIC ACID; PHOSPHORUS; SODIUM THIOSULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM URINE LEVEL; CONTROLLED STUDY; HYPERCALCIURIA; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; RAT; STONE FORMATION; URINALYSIS; URINE PH;

EID: 67449108010     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008070754     Document Type: Article

References (37)

1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC: Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63: 1817-1823, 1999
2. Litwins J, Boyd LJ, Greenwald L: The action of sodium thiosulfate on the blood. Exp Med Surg 1: 252-258, 1943
3. Theis FV, Freeland MR: Thromboangiitis obliterans. Surgery 11: 101-117, 1942
4. Baskin SI, Horowitz AM, Nealley EW: The antidotal action of sodium nitrite and sodium thiosulfate against cyanide poisoning. J Clin Pharmacol 32: 368-375, 1992
5. Howell SB, Pfeifle CL, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M: Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 97: 845-851, 1982 (Pubitemid 13240565)
6. Pfeifle CE, Howell SB, Felthouse RD, Woliver TB, Andrews PA, Markman M, Murphy MP: High-dose cisplatin with sodium thiosulfate protection. J Clin Oncol 3: 237-244, 1985 (Pubitemid 15153767)
7. Yatzidis H: Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol 23: 63-67, 1985 (Pubitemid 15130159)
8. Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR: Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol 1: 1161-1166, 2006
9. Mataic D, Bastani B: Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis. Ren Fail 28: 361-363, 2006 (Pubitemid 43977349)
10. Brucculeri M, Cheigh J, Bauer G, Serur D: Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial 18: 431-434, 2005 (Pubitemid 41545879)
11. Yatzidis H, Agroyannis B: Sodium thiosulfate treatment of soft-tissue calcifications in patients with end stage renal disease. Perit Dial Bull 7: 250-252, 1987 (Pubitemid 18083953)
12. Guerra G, Shah RC, Ross EA: Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: Case report. Nephrol Dial Transplant 20: 1260-1262, 2005 (Pubitemid 40862124)
13. Papadakis JT, Patrikarea A, Digenis GE, Stamatelou K, Ntaountaki I, Athanasopoulos V, Tamvakis N: Sodium thiosulfate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism. Nephron 72: 308-312, 1996 (Pubitemid 26035395)
14. Landau D, Krymko H, Shalev H, Agronovich S: Transient severe metastatic calcification in acute renal failure. Pediatr Nephrol 22: 607-611, 2007 (Pubitemid 46332345)
15. Cicone JS, Petronis JB, Embert CD, Spector DA: Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 43: 1104-1108, 2004 (Pubitemid 38691507)
16. Meissner M, Bauer R, Beier C, Betz C, Wolter M, Kaufmann R, Gille J: Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis. Dermatology 212: 373-376, 2006
17. Bushinsky DA, Frick KK, Nehrke K: Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 15: 403-418, 2006 (Pubitemid 44297983)
18. Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ: Increased intestinal vitamin D receptor in genetic hypercalciuric rats: A cause of intestinal calcium hyperabsorption. J Clin Invest 91: 661-667, 1993 (Pubitemid 23064152)
19. Bushinsky DA, Favus MJ: Mechanism of hypercalciuria in genetic hypercalciuric rats: Inherited defect in intestinal calcium transport. J Clin Invest 82: 1585-1591, 1988 (Pubitemid 19007763)
20. Tsuruoka S, Bushinsky DA, Schwartz GJ: Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 51: 1540-1547, 1997 (Pubitemid 27239910)
21. Bushinsky D, Neumann K, Asplin JR, Krieger N: Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55: 234-243, 1999 (Pubitemid 29004255)
22. Krieger NS, Stathopoulos VM, Bushinsky DA: Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats. Am J Physiol 271: C130-C135, 1996
23. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL: Stone formation in genetic hypercalciuric rats. Kidney Int 48: 1705-1713, 1995
24. Bushinsky DA, Parker WR, Asplin JR: Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57: 550-560, 2000 (Pubitemid 30430647)
25. Werness PG, Brown CM, Smith LH, Finlayson B: EQUIL 2: A basic computer program for the calculation of urinary saturation. J Urol 134: 1242-1244, 1985 (Pubitemid 16207045)
26. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A: Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158: 2069-2073, 1997 (Pubitemid 27481329)
27. Ettinger B, Citron JT, Livermore B, Dolman LI: Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139: 679-684, 1988 (Pubitemid 18104987)
28. Laerum E, Larsen S: Thiazide prophylaxis of urolithiasis: A doubleblind study in general practice. Acta Med Scand 215: 383-389, 1984 (Pubitemid 14111516)
29. Barcelo P, Wuhl O, Servitge E, Roussaud A, Pak C: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150: 1761-1764, 1993 (Pubitemid 24350792)
30. Borghi L, Meschi T, Guerra A, Novarini A: Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22[Suppl 6]: S78-S86, 1993 (Pubitemid 23346741)
31. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M: Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111: 607-616, 2003 (Pubitemid 36278579)
32. Agroyannis BJ, Koutsikos DK, Tzanatos HA, Konstadinidou IK: Sodium thiosulphate in the treatment of renal tubular acidosis I with nephrocalcinosis. Scand J Urol Nephrol 28: 107-108, 1994 (Pubitemid 24112201)
33. Curhan GC, Willett WC, Speizer FE, Stampfer MJ: Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59: 2290-2298, 2001 (Pubitemid 32467623)
34. Bushinsky DA, Grynpas MD, Asplin JR: Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone forming rats. Kidney Int 59: 1415-1423, 2001 (Pubitemid 32281230)
35. Yerram P, Saab G, Karuparthi PR, Hayden MR, Khanna R: Nephrogenic systemic fibrosis: A mysterious disease in patients with renal failure- Role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol 2: 258-263, 2007
36. Pak CY, Chu S: A simple technique for the determination of urinary state of saturation with respect to brushite. Invest Urol 11: 211-215, 1973
37. Pak CY: Physicochemical basis for formation of renal stones of calcium phosphate origin: Calculation of the degree of saturation of urine with respect to brushite. J Clin Invest 48: 1914-1922, 1969